What is the NOAEL for Kojic acid?
Kojic acid has 45 NOAEL studies in the database. The lowest reported value is 0.003 % via oral in rat. Source: SCCS Opinion.
Also known as: 5-18-02-00516, BRN 0120895, EINECS 207-922-4, 5-Hydroxy-2-(hydroxymethyl)-4-pyrone, UNII-6K23F1TT52 (+2 more)
CAS 501-30-4
Kojic acid (CAS 501-30-4) is a chemical substance; key hazard signal: IARC Group 3. Key regulatory status: 2 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, SCCS, IARC.
CAS, identifiers, formula, and alternate names for the matched substance record.
Carcinogenic hazard classification from IARC monograph evaluations.
| Group | Meaning | Evaluated | Volume |
|---|---|---|---|
| Group 3 | Not classifiable | 2000 | 79 |
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| Canada; Personal care; Substances in PCP - Canada (4/2014) | Government of Canada | CPCat |
| Canada; pharmaceutical | DrugBank | DrugBank |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 0.03 | % | - | oral | rat | Regulatory source |
| 0.03 | % | - | - | rat | Regulatory source |
| 0.5 | % | - | oral | rat | Regulatory source |
| 1 | % | - | - | guinea pig | Regulatory source |
| 2 | % | - | oral | rat | Regulatory source |
| 2 | - | - | - | - | Regulatory source |
| 5.85 | mg/kg bw/day | - | oral | rat | Regulatory source |
| 6 | mg/kg bw/day | - | oral | rat | Regulatory source |
| 6 | mg/kg bw | - | oral | rat | Regulatory source |
| 6 | mg/kg bw/day | - | - | - | Regulatory source |
| 15 | mg/kg bw/day | - | - | rat | Regulatory source |
| 15.5 | mg/kg bw | - | oral | rat | Regulatory source |
| 23.8 | mg/kg bw/day | - | oral | rat | Regulatory source |
| 40 | - | - | - | - | Regulatory source |
| 62.5 | mg/kg bw/day | - | - | rat | Regulatory source |
| 62.5 | mg/kg bw/day | - | oral | rat | Regulatory source |
| 68 | - | - | - | - | Regulatory source |
| 100 | mg/kg/day | - | oral | rat | Regulatory source |
| 100 | mg/kg bw/day | - | - | rat | Regulatory source |
| 100 | mg/kg bw | - | oral | rat | Regulatory source |
| 100 | mg/kg bw | - | - | rat | Regulatory source |
| 125 | mg/kg | - | dermal | rat | Regulatory source |
| 125 | mg/kg bw/day | - | dermal | rat | Regulatory source |
| 150 | mg/kg bw/day | - | - | mouse | Regulatory source |
| 150 | mg/kg bw/day | - | oral | mouse | Regulatory source |
| 227 | mg/kg bw/day | - | oral | rat | Regulatory source |
| 1637 | - | - | - | human | Regulatory source |
| 6K23F1TT52 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 3 | IARC group | IARC carcinogenicity classification | - | - | IARC Monographs |
| 3 | unitless | IARC group | - | - | NTP ICE cancer |
| 5.85 | mg/kg bw/day | LOAEL | oral | rat | COSMOS DB |
| =0.003 | % | NOAEL | oral | rat | SCCS Opinion |
| =0.03 | % | NOAEL | oral | rat | SCCS Opinion |
| =0.069 | mg/kg | NOAEL | oral | rat | SCCS Opinion |
| =0.079 | mg/kg | NOAEL | oral | rat | SCCS Opinion |
| =0.104 | mg/kg | NOAEL | oral | rat | SCCS Opinion |
| =0.12 | mg/kg | NOAEL | oral | rat | SCCS Opinion |
| =0.173 | mg/kg | NOAEL | oral | rat | SCCS Opinion |
| =0.199 | mg/kg | NOAEL | oral | rat | SCCS Opinion |
| =0.5 | % | NOAEL | oral | rat | CIR Safety Assessment |
| =0.5 | % | NOAEL | oral | rat | SCCS Opinion |
| =1 | % | NOAEL | - | guinea pig | CIR Safety Assessment |
| =2 | mg/kg bw/d | NOAEL | oral | rat | SCCS Opinion |
| =2 | % | NOAEL | oral | rat | SCCS Opinion |
| =2 | - | NOAEL | - | - | SCCS Opinion |
Showing 45 of 45 studies
EU Scientific Committee opinions tied to the matched substance.
| Opinion | Date | Conclusion | Max Conc. | Concerns |
|---|---|---|---|---|
| SCCS/1637/21 | 15-16 March 2022 | safe with restrictions | 1% as skin lightening agent in leave-on creams | Endocrine disrupting properties (potential thyroid effects); 1% in leave-on products safe; not to exceed 0.04% combined use in multiple cosmetics |
| SCCS/1481/12 | 26-27 June 2012 | safe with restrictions | 1% in leave-on creams (face/hands) | Potential endocrine effects; skin sensitisation potential; concerns about thyroid effects - subject to revision (see SCCS/1637/21) |
| SCCP/1171/08 | 30 September 2008 | safe with restrictions | 1% in leave-on products | Skin lightening; sensitisation potential; thyroid effects questioned; see updated opinion SCCS/1637/21 |
| SCCP/1182/08 | 30 September 2008 | Based on the information provided, margins of safety of respectively 35 (face and hands), 58 (hands) and 88 (face) have been calculated suggesting that the use of Kojic acid at a maximum concentration of 1.0% in skin care formulations poses a risk to the health of the consumer. | 1.0% | Margins of safety of 35 (face and hands), 58 (hands), 88 (face) — use at 1.0% poses a risk to consumer health; other parts of skin might also be exposed. Kojic acid has the potential to induce skin sensitisation. Mixed in vitro mutagenicity (positive in bacteria, some clastogenicity in vitro) though negative in vivo. Slightly photoirritant. Relevant kinetics data may refine the MoS approach. |
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Kojic acid has 45 NOAEL studies in the database. The lowest reported value is 0.003 % via oral in rat. Source: SCCS Opinion.
Kojic acid appears on 2 regulatory/inventory lists including Canada; Personal care; Substances in PCP - Canada (4/2014), Canada; pharmaceutical. Source: EPA CPDat.
Kojic acid is classified by IARC as Group 3 — not classifiable as to its carcinogenicity to humans (evaluated 2000). Source: IARC Monographs on the Identification of Carcinogenic Hazards to Humans.
Yes, Kojic acid is also indexed as a cosmetic ingredient under the name Kojic Acid. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, EPA DSSTox, IARC Monographs, CosIng / Ingredients DB, ChEMBL / DailyMed. All data traces to primary regulatory sources and is updated from official government databases.
Kojic acid also appears in cosmetics, pharmaceutical databases.